Image-Guided Cancer Interventions (STTR[R41/R42]), (SBIR[R43/R44])
STTR PA-10-080 (STTR[R41/R42]): http://grants.nih.gov/grants/guide/pa-files/PA-10-080.html
SBIR PA-10-081 (SBIR[R43/R44]): http://grants.nih.gov/grants/guide/pa-files/PA-10-081.html
Expiration dates: January 8, 2013
Keyvan Farahani, Ph.D.
These announcements support the development and clinical validation of systems for IGIs for cancer. Specifically, the goals of this program are to provide support for: the development and optimization of fully integrated cancer imaging, monitoring, and therapy systems; the validation of integrated IGI systems through clinical evaluations; the development of multiple prototype integrated IGI systems as required for multisite clinical evaluations; and partnerships among small business, large business, and academic clinical centers, as well as small business joint ventures, in order to reach the research goals.
Paula M. Jacobs, Ph.D., is Associate Director, Cancer Imaging Program in the Division of Cancer Treatment and Diagnosis at the National Cancer Institute. She came to work at the NCI after 30 years in the pharmaceutical and medical device industries where she was a key developer of ultrasmall superparamagnetic iron oxide drugs as magnetic resonance imaging agents and iron replacement therapeutics. More…